Physician

Jesus Luigi Borrillo, MD

According to 2025 Medicare claims, Jesus Borrillo, MD (NPI: 1861487100) practices ophthalmology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (NPI: 1538275920; TIN: 942906234) and primary practice location at 95124-4002.

Borrillo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 893 traditional Medicare patients, billed 13,152 HCPCS/CPT codes, and received $1,732,342 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 681 prescription claims across 219 beneficiaries totaling $27,873 in drug costs, led by Lumigan (Bimatoprost). Open Payments data shows 5 records totaling $225. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $882,748 to $1,732,342. In contrast, Part D prescription costs have fallen sharply in recent years, from $71,988 to $27,873. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.0M$2.0M2015 Medicare payment: $882,748 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $1,080,726 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,179,094 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $1,421,772 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $1,720,350 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $1,672,201 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,010,200 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $1,780,134 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,683,889 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $1,732,342 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157637,128$882,748
20167797,902$1,080,726
20178197,854$1,179,094
20188858,780$1,421,772
20199119,283$1,720,350
20207897,973$1,672,201
20218418,454$2,010,200
20227927,618$1,780,134
20238329,474$1,683,889
202489313,152$1,732,342

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$41K$82K2015 Drug cost: $71,988 (USD; Tot_Drug_Cst)2016 Drug cost: $76,297 (USD; Tot_Drug_Cst)2017 Drug cost: $80,116 (USD; Tot_Drug_Cst)2018 Drug cost: $82,261 (USD; Tot_Drug_Cst)2019 Drug cost: $75,046 (USD; Tot_Drug_Cst)2020 Drug cost: $62,541 (USD; Tot_Drug_Cst)2021 Drug cost: $55,609 (USD; Tot_Drug_Cst)2022 Drug cost: $40,821 (USD; Tot_Drug_Cst)2023 Drug cost: $45,951 (USD; Tot_Drug_Cst)2024 Drug cost: $27,873 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015143499$71,988
2016173658$76,297
2017164618$80,116
2018160547$82,261
2019159522$75,046
2020130474$62,541
2021159553$55,609
2022178680$40,821
2023197636$45,951
2024219681$27,873

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1981,604$650
67028Injection of drug into eye2701,176$113
92012Established patient problem focused exam of visual system156162$85
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more7281,607$83
92134Imaging of retina8192,343$41

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
LumiganBimatoprost11427$3,209
Brimonidine TartrateBrimonidine Tartrate372,005$2,548
ErythromycinErythromycin Base1831,993$1,798
Prednisolone AcetatePrednisolone Acetate381,444$1,055
TravoprostTravoprost11315$997

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$225RxSight Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jesus Luigi Borrillo, MD?

Tedicare shows public-source Medicare data for Jesus Luigi Borrillo, MD (NPI 1861487100), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jesus Luigi Borrillo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Jesus Luigi Borrillo, MD?

Jesus Luigi Borrillo, MD is linked to NORTHERN CALIFORNIA RETINA VITREOUS ASSOCIATES MEDICAL GROUP, INC. (billing NPI 1538275920) in the available physician profile data.

Does Jesus Luigi Borrillo, MD have Open Payments data?

Jesus Luigi Borrillo, MD has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.